In a study of people with PTSD, participants who took ZADIOL™ experienced a significant improvement in chronic anxiety and quality of life.
Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON-366
Published: 30 April 2019
What is PTSD?
PTSD is typically regarded as an interaction between the subject, a traumatic event, and social contexts that cause the physical stress component to persist as a chronic condition resulting from the mental stress component. PTSD has been observed to have a profound effect on immunity and inflammatory disorders. A strong correlation exists between the onset of PTSD and SMD-related stress with immune system dysfunction and chronic diseases containing an inflammatory component.
Individuals may develop PTSD after being exposed to a traumatic event such as combat experiences, a motor vehicle crash, or sexual assault. Symptoms of PTSD may include nightmares, intrusive thoughts, or other re-experiencing phenomena, the avoidance of situations that remind the person of the traumatic event, a feeling of numbness or being socially detached from family and friends, and hyper-arousal (for example, feeling angry, irritable and “on edge,” or having difficulty concentrating). Hyper-arousal or hyper-vigilance includes a rapid and pronounced reaction to stressors which may lead to a preoccupation with signs of threat and emotional distress. Persons with PTSD may have other challenges such as difficulties with employment, relationships, or other health conditions (for example – depression, alcohol abuse, or drug dependency).